- AI analytics across trial data operations
- Stays focused on real clinical trials buyer problems
- Scales to organization-wide healthcare rollouts
Saama
AI analytics across clinical trial data
SF7.5
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Discover patient cohorts across dataLife sciences and clinical operations
Discover patient cohorts across dataLife sciences and clinical operations
Best for
Life sciences and clinical operations
Pricing
Custom
SoftFinders Score
7.5 / 10
Overview
What is Saama?
Saama is an AI clinical analytics company that accelerates clinical trial data review and operations for life sciences. The product is positioned around research operations, evidence generation, and trial workflow rather than guaranteed trial outcomes, and research governance and oversight remain essential parts of any clinical program. Buyers should confirm data access model, study design support, regulatory framing, and reporting depth before adopting across active research operations and trial portfolios at scale.
The clearest fit for Saama is life sciences and clinical operations, and the product leans into AI analytics across trial data operations. One real limitation: value tied to trial portfolio scale. Pricing is sales-led and scoped per buyer rather than posted publicly. Confirm validation depth, support coverage, and the rollout plan before signing.
KEY FEATURES
What you get out of the box
Literature Intelligence
Mines literature for research signals
Research Workflow
Workflows for research operations teams
Federated Learning
Federated learning across distributed data
Recruitment Support
Supports recruitment for active trials
Trial Matching
Matches patients to relevant clinical trials
Real World Evidence
Generates rapid real-world evidence studies
USE CASES
Where teams put it to work
Discover patient cohorts across data
Assess trial protocol feasibility
Run federated research across institutions
Support trial recruitment workflows
Match patients to relevant trials
Generate real-world evidence studies
Editorial Take
What we like, and what to verify
- Value tied to trial portfolio scale
- Recruitment outcomes still depend on study design
- Pricing is sales-led and needs scoping upfront
Screenshots
A look inside
Alternatives
Tools to consider next
Unlearn.AI SF 7.4
Why consider it
Digital twins for clinical trial efficiency
Sully.ai SF 7.6
Why consider it
All-in-one AI scribe and clinician assistant
Tali AI SF 7.5
Why consider it
Voice AI scribe with built-in medical search
Doximity GPT SF 7.4
Why consider it
Free clinical writing assistant for verified physicians
FAQ